For generations, millions of women have been told they have
Polycystic Ovary Syndrome, or PCOS: a name that sounds almost “quaint”, conjuring images of mysterious cysts tucked inside the ovaries. But the reality has always been far more complex, and far more whole-body, than that label suggested for a century. Now, after decades of advocacy and evolving science, experts are giving the condition a fresh identity: PMOS, or PolyMetabolic Ovary Syndrome (sometimes described as Polyendocrine Metabolic Ovarian Syndrome).
This is more than a cosmetic tweak. It’s a fundamental shift in how we understand one of the most common medical conditions affecting women – young, reproductive age, and one that continues to ripple through their health long after childbearing years.

For generations, millions of women have been told they have Polycystic Ovary Syndrome, or PCOS: a name that sounds almost “quaint”, conjuring images of mysterious cysts tucked inside the ovaries. But the reality has always been far more complex, and far more whole-body. Now, after decades of advocacy and evolving science, experts are giving the condition a fresh identity: PMOS, or Polymetabolic Ovary Syndrome (sometimes described as Polyendocrine Metabolic Ovarian Syndrome).
The problem with just “cysts”
The story begins in 1935, when two American doctors noticed enlarged ovaries dotted with small sacs in women struggling with irregular periods and infertility. They called it polycystic ovary syndrome, and the name stuck. The trouble is, those “cysts” aren’t true cysts at all. They’re immature egg follicles whose development has stalled because of deeper hormonal chaos. Many women with the condition don’t even have them visible on scans.
Yet the old name kept the conversation narrowly focussed on ovaries and reproduction. For a century. It led patients and doctors alike to believe this was primarily a fertility or “women’s troubles” issue. And we all know how “women’s trouble issues” are treated all over the world. To call it abysmal would be understating things. While PMOS can lead to irregular menstrual periods, abnormal ovulation, excess facial or body hair, acne, and sometimes infertility, it is also associated with significant endocrine, metabolic, psychological, and dermatological symptoms.These can persist far beyond a person's reproductive years.
The previous name, PCOS, reflected only one organ and failed to capture the disorder's multisystem nature. A travesty considering, today, PMOS impacts roughly 170 million women worldwide, and it's estimated that up to 70 per cent of patients go undiagnosed. Dr. David Chandy, director, endocrinology, Sir HN Reliance Hospital says, "The transition to
PMOS (Polyendocrine Metabolic Ovarian Syndrome) is a clinical milestone that refines our long-standing understanding of women's health. For too long, the term 'polycystic' suggested that ovarian cysts were the primary issue, yet many patients never develop them. By incorporating 'polyendocrine' and 'metabolic' into the name, we are finally aligning terminology with the root cause: a complex hormonal and insulin imbalance. This shift helps strip away the stigma of 'cysts' and empowers patients to see that lifestyle management—diet, exercise, and sleep—is not just a secondary recommendation, but the primary treatment for what is truly a systemic endocrine disorder."
Dr Muskaan Chhabra, fertility specialist at Birla Fertility & IVF, New Delhi, says the renaming is a clinically significant development that those of working in reproductive medicine have welcomed as a necessary evolution in how PMOS is understood globally. "Many patients in India were told they had PCOS for decades. And even this term, which we now know was myopic in scope, always remained an informal with an ovary-focused description that did not capture the hormonal and metabolic complexity as underlying the conditions.”
What exactly is PMOS then?

PMOS is a multisystem condition driven by insulin resistance (this is the most crucial discovery), hormonal imbalance, chronic low-grade inflammation, and genetic factors. It touches metabolism, heart health, skin, mood, and energy levels.
PMOS is a multisystem condition driven by insulin resistance (this is the most crucial discovery), hormonal imbalance, chronic low-grade inflammation, and genetic factors. It touches metabolism, heart health, skin, mood, and energy levels. Dr. Helena Teede, an Australian endocrinologist who has led the renaming effort, puts it plainly: the ovaries are involved, but they are not the origin story. The disruption often runs deeper – possibly even beginning in the brain’s signaling pathways.
Dr. Manisha Arora, director, internal medicine at CK Birla Hospital, Delhi, says the previous name, Polycystic Ovarian Syndrome (PCOS), didn't describe the condition accurately. “Because many women think they do not have PCOS if they do not have visible cysts on an ultrasound. In reality, women who have hormonal and metabolic problems often have normal-looking ovaries on an ultrasound. This has led to some women being diagnosed very late or not being diagnosed at all. The new name, PMOS, will help women understand that what they have is not just an ovarian problem. It’s a complicated endocrine and metabolic problem affecting insulin, testosterone, cortisol, and many different systems of the body.” What this does is help create more awareness about the condition, clear up any confusion about it, and encourage women to get medical help sooner rather than later.
Dr Satish Koul, principal director and unit head, internal medicine, FMRI, says renaming PCOS as PMOS is an important shift because the condition is far more than an ovarian disorder. “Not every woman with polycystic ovaries has PCOS, and not every woman with PCOS actually has polycystic ovaries,” he says, adding that the older term failed to capture the broader hormonal and metabolic nature of the condition.
According to him, PMOS better reflects the endocrine and metabolic complications linked to the disorder, especially insulin resistance. “Patients can experience ovarian issues, hormonal imbalance, metabolic dysfunction, and even mental-health challenges, which is why treatment now requires a multidisciplinary approach, not just gynecological care.” He explains that the condition evolves across a woman’s life. “In adolescence, symptoms may include acne or facial hair. In their 20s, women may struggle with conception, and by their 30s, many are at risk of diabetes because PMOS is strongly linked to insulin resistance.”

PCOS kept the conversation narrowly focussed on ovaries and reproduction. It led patients and doctors alike to believe this was primarily a fertility or “women’s troubles” issue. While PMOS can lead to irregular menstrual periods, abnormal ovulation, excess facial or body hair, acne, and sometimes infertility, it is also associated with significant endocrine, metabolic, psychological, and dermatological symptoms. These can persist far beyond a person's reproductive years.
Dr. Koul also says the renaming may help reduce stigma around weight gain. “It tells women that weight gain is not simply a lifestyle issue or a result of laziness, but part of a complex metabolic condition. That understanding can greatly improve mental wellbeing.” He adds that genetic testing in young patients could help doctors plan more personalized, long-term treatment strategies.
What it actually feels like
If you have PMOS, the symptoms can feel like a scattered puzzle. Irregular or absent periods. Acne that lingers into adulthood. Unwanted facial or body hair. Thinning hair on the scalp. Difficulty conceiving. Stubborn weight gain, especially around the middle. Crushing fatigue. Anxiety or low mood. And behind the scenes: insulin resistance that raises the long-term risk of Type 2 diabetes, fatty liver, high blood pressure, sleep apnea, and cardiovascular disease. It’s impossible to see or even realize all these symptoms may lead to a diagnosis of PMOS. There are so many things women attribute to hormones, and let it go.
Dr. Anuranjita Pallavi, senior consultant gynaecologist and fertility & IVF specialist, Motherhood Fertility & IVF, Navi Mumbai, says, many women who remained undiagnosed will get diagnosed now. "For instance, many women with PMOS report medical gaslighting because symptoms of hormonal imbalance, insulin resistance, and weight gain are often dismissed or labelled as “emotional issues” not worth further probing. Sometimes, these symptoms are also mistaken for stress, poor diet, or disrupted mental well-being. It take a huge toll on women's health." Dr Pallavi urges women to look for certain signs: Irregular periods, excessive facial and body hair, acne, and sudden weight gain. They are all indication of PMOS.”

Renaming PCOS to PMOS leads to better mental wellbeing because it tells women weight gain is not all about the hormones, rather it's excessive insulin. The problem is metabolic and endocrine. Women don't have to live with stigma anymore.
One of the most crucial parts of PMOS is that one doesn’t even need to be overweight to have it. Many “lean” women battle the same metabolic and hormonal storms. And the condition doesn’t politely retire after menopause. It can continue to influence metabolic health for years.
We’ve already said that globally, it affects roughly 170 million women. In India, where rising obesity, stress, processed diets, and sedentary lifestyles have collided with genetic predisposition, diagnoses among young women have climbed sharply. Yet up to 70 per cent still go undiagnosed, often because symptoms are dismissed as “normal girl stuff” or blamed solely on lifestyle.
Why the name change matters
Patient surveys and years of discussion—sparked at a 2012 NIH meeting and culminating in a recent Lancet paper—showed overwhelming support for change. The old name confused patients (“But my ultrasound was clear—do I still have it?”) and limited doctors’ thinking. Gynecologists might prescribe the pill to regulate cycles, while metabolic red flags went unaddressed.
PMOS now acknowledges the condition as a multisystem endocrine and metabolic disorder, in which the ovaries are just one of several systems involved rather than the primary site of the problem. "For patients who have received any of these diagnoses, what matters most is that this progression in nomenclature reflects a growing commitment to seeing and treating the person holistically – including irregular ovulation, delayed conception and fertility planning. We expect it will encourage a wider conversation in our country about the importance of thorough, integrated fertility and hormonal care for women," adds Dr Pallavi.
Rachel Morman, who chairs the UK charity Verity and lives with the condition, has heard countless stories of women leaving appointments in tears, simply because someone finally listened and explained the bigger picture. The new name, PMOS, spotlights the metabolic and endocrine heart of the disorder. It signals to everyone—patients, doctors, researchers, insurers—that this is a chronic, whole-body condition deserving broad attention, not just reproductive management.
Dr Santosh Bangar, senior consultant psychiatrist at Gleneagles Hospital, Mumbai, talks about the future possibility of a positive impact on mental well-being of women due to this holistic approach. “PMOS is a common but complex condition. Delayed diagnosis or dismissal leaves women frustrated and exhausted because no one listens or understands them. The missed periods, facial and body hair, acne and insulin resistance, can all affect relationships, fertility, and confidence. It's human. And this causes more anxiety and self-doubt, which eventually leads to depression."

PMOS now acknowledges the condition as a multisystem endocrine and metabolic disorder, in which the ovaries are just one of several systems involved rather than the primary site of the problem. For patients who have received any of these diagnoses, what matters most is that this progression in nomenclature reflects a growing commitment to seeing and treating the person holistically
PMOS diagnosis is now simpler than it used to be
You no longer need an ultrasound to confirm PMOS. Current guidelines require just two of three features:
- High levels of androgens (male-type hormones like testosterone) — either through blood tests or clear physical signs like excess hair or acne.
- Irregular or absent ovulation/menstrual cycles.
- Either many immature follicles on ultrasound or elevated anti-Müllerian hormone (AMH) in blood.
For most women, the first two criteria are enough. A simple blood test can often replace an uncomfortable internal scan. This shift should make diagnosis faster, cheaper, and less invasive.
Treatment: Moving beyond the pill
The renaming has also opened the door to smarter, more comprehensive care. Instead of defaulting to hormonal contraceptives for symptom control, clinicians are increasingly looking at the metabolic roots. Lifestyle remains foundational: regular movement (especially strength training and brisk walking), quality sleep, stress management, and a diet that stabilises blood sugar are all needed. These changes can dramatically improve insulin sensitivity, hormone balance, and overall well-being; even in women who don’t lose much weight. This is important. So, the PMOS would still be treated with a multidisciplinary health approach. The weight is another factor that a nutritionist will be able to help with.
In fact, newer options like GLP-1 medications (the class behind drugs such as semaglutide) are showing promise for tackling insulin resistance and supporting sustainable weight management. Multidisciplinary teams—endocrinologists, nutritionists, dermatologists, psychologists, and trainers—are becoming the gold standard.
But the most important outcome of the renaming is that mental health support is no longer an afterthought. The hormonal rollercoaster, combined with visible symptoms and fertility worries, takes a real toll on confidence and mood of women all over the world. Addressing anxiety, depression, and body image is now seen as core treatment of PMOS.
A wider cultural shift
Hence, the move from PCOS to PMOS mirrors a larger evolution in women’s health. For too long, female hormonal issues were siloed in gynecology and reduced to reproduction. Today we understand hormones influence everything from heart disease risk to brain health, immunity, and how we age. Dr. Bushra Khan, Fertility Specialist, Nova IVF Fertility, Kharadi, Pune, points out this pertinent problem that can be resolved with renaming PCOS as PMOS. "The traditional name led to confusion, with many patients focussing solely on ovarian cysts, although the condition is mainly driven by hormonal imbalance and insulin resistance. Some women often display polycystic ovarian morphology through ultrasound testing, yet they do not possess the actual condition. The existing overlap between these two conditions has created difficulties in both diagnosing patients and providing them with counselling services.”

From 1935 to the end of the 1970s, he explains, research was mostly focused on the hormonal aspects of PCOS. In the last two decades of the 20th century, however, the focus shifted to metabolic issues involving hormones such as insulin.
In a world of ultra-processed food, chronic stress, and disrupted sleep, metabolic and hormonal disorders are rising across the board. Reframing PMOS as a metabolic-endocrine condition helps destigmatise it, attract better research funding, and push for earlier screening, especially in high-risk groups like those with family histories of diabetes.
Dr Bangar asks young girls and parents to be look out for signs, which leads to early diagnosis and better patient outcome. "Young girls may struggle with concerning symptoms such as acne, weight gain, irregular periods, excessive hair growth and can be mocked or ridiculed by others. They can feel as if something is wrong with them. They can struggle to accept themselves due to the false expectations set by the society and social media. They may avoid socializing and feel lonely. They may feel they are not good enough, which may affect self confidence and self esteem.” It’s essential to know if all these conditions are due to PMOS, because right diagnosis leads to right treatment.
The road ahead
The new name, PMOS, will roll out gradually. By 2028, it should appear in the International Classification of Diseases, standardizing records and research worldwide. Some pushback is expected from brands and influencers heavily invested in “PCOS” awareness, but the women living with the condition have made their preference clear.
For patients, this rebrand is quietly revolutionary. It replaces confusion and “shame” with clarity and legitimacy. It tells a woman struggling with stubborn weight, relentless acne, and crushing periods that her body isn’t “broken” in some mysterious ovarian way; it’s dealing with a recognizable, manageable metabolic-hormonal pattern that modern medicine is finally learning to address holistically.
If you suspect you might have PMOS, don’t wait for perfect cysts on a scan. Track your cycles, note symptoms, and seek a doctor to test androgens, insulin markers, and AMH. The right name won’t magically cure anything, but it can be the first step toward truly being heard, properly screened, and effectively treated.
Because women’s health isn’t just about ovaries. It’s about whole, vibrant lives. And it looks like medicine is finally catching up; after a long, hard struggle by women worldwide.